Basel, Basel-Stadt, Switzerland In 1996 was created Erfindungs Verwertung, which is appeared as VC. The company was established in Europe in Switzerland. The main department of described VC is located in the Basel.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. We can highlight the next thriving fund investment areas, such as Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Covalys Biosciences.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are VI Partners AG, Novartis Venture Fund. In the next rounds fund is usually obtained by Venture Incubator, LLC, Novartis, BVGroup.
The common things for fund are deals in the range of 1 - 5 millions dollars. The high activity for fund was in 2005. The fund is constantly included in less than 2 investment rounds annually.
Funds with similar focus
| Fund Name | Location |
| Aura Ventures | Australia, New South Wales, Sydney |
| Globalive Communications | Canada, Ontario, Toronto |
| Haima Touzi | China, Ningbo Shi, Zhejiang |
| MCJ | Japan, Kasukabe, Saitama Prefecture |
| Medicash | - |
| New Sustainable Growth | Japan, Niigata, Niigata Prefecture |
| Ogden Pond Group | Canada, Halifax, Ontario |
| One Capital | China, Guangdong, Shenzhen |
| Sumitomo Corporation of America | New York, New York, United States |
| Sustainable Technologies Fund | Stockholm, Stockholm County, Sweden |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | $2M | 01 Feb 2005 | Bern, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Covalys Biosciences | $2M | 01 Feb 2005 | Bern, Switzerland |
